Literature DB >> 28472426

Chemical or Drug Hypersensitivity: Is the Immune System Clearing the Danger?

Marc Pallardy1, Rami Bechara1.   

Abstract

Hypersensitivity reaction or allergy, initially perceived as a secondary disorder, is now believed to be a major public health concern. For instance, contact dermatitis is a type IV delayed-type hypersensitivity reaction to skin allergens. An estimated 15%-20% of the general population has acquired contact allergy. To maintain immune tolerance, our immune system needs to differentiate between harmful non-self and innocuous non-self. Living organisms have developed during their evolution a set of biological mechanisms to protect them from the "outside": physical barrier, inflammation, cell-based mechanisms, metabolism and elimination, and biochemical pathways such as glutathione. The innate and adaptive immune systems are also involved in the protection from the "outside" by mounting specific or non-specific responses leading to the clearance of dangerous triggers such as viruses, bacteria, or parasites. In the case of chemical or drug allergy, is our immune system clearing the danger resulting from environmental exposure to these harmful chemicals with a true immune response? Is the immune system then triggered specifically for its role: clearing a specific problem? Alternatively, should we perceive chemical or drug hypersensitivity as an accident with uncontrolled consequences leading to immunopathology?
© The Author 2017. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  chemical allergy; hypersensitivity; immunopathology; immunotoxicity; immunotoxicology

Mesh:

Substances:

Year:  2017        PMID: 28472426     DOI: 10.1093/toxsci/kfx084

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  4 in total

1.  Identification and Characterization of Circulating Naïve CD4+ and CD8+ T Cells Recognizing Nickel.

Authors:  Rami Bechara; Sabrina Pollastro; Marie Eliane Azoury; Natacha Szely; Bernard Maillère; Niek de Vries; Marc Pallardy
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

2.  Low prevalence of anti-xenobiotic antibodies among the occupationally exposed individuals is associated with a high risk of cancer.

Authors:  Mohammad Sajid; Javed N Agrewala
Journal:  Cancer Med       Date:  2018-12-21       Impact factor: 4.452

3.  Consensus on the Key Characteristics of Immunotoxic Agents as a Basis for Hazard Identification.

Authors:  Dori R Germolec; Herve Lebrec; Stacey E Anderson; Gary R Burleson; Andres Cardenas; Emanuela Corsini; Sarah E Elmore; Barbara L F Kaplan; B Paige Lawrence; Geniece M Lehmann; Curtis C Maier; Cliona M McHale; L Peyton Myers; Marc Pallardy; Andrew A Rooney; Lauren Zeise; Luoping Zhang; Martyn T Smith
Journal:  Environ Health Perspect       Date:  2022-10-06       Impact factor: 11.035

Review 4.  Drug and Chemical Allergy: A Role for a Specific Naive T-Cell Repertoire?

Authors:  Rami Bechara; Alexia Feray; Marc Pallardy
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.